Literature DB >> 20400112

Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention.

Diana L Diesen1, Paul C Kuo.   

Abstract

Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are created in normal hepatocytes and are critical for normal physiologic processes, including oxidative respiration, growth, regeneration, apoptosis, and microsomal defense. When the levels of oxidation products exceed the capacity of normal antioxidant systems, oxidative stress occurs. This type of stress, in the form of ROS and RNS, can be damaging to all liver cells, including hepatocytes, Kupffer cells, stellate cells, and endothelial cells, through induction of inflammation, ischemia, fibrosis, necrosis, apoptosis, or through malignant transformation by damaging lipids, proteins, and/or DNA. In Part I of this review, we will discuss basic redox biology in the liver, including a review of ROS, RNS, and antioxidants, with a focus on nitric oxide as a common source of RNS. We will then review the evidence for oxidative stress as a mechanism of liver injury in hepatitis (alcoholic, viral, nonalcoholic). In Part II of this review, we will review oxidative stress in common pathophysiologic conditions, including ischemia/reperfusion injury, fibrosis, hepatocellular carcinoma, iron overload, Wilson's disease, sepsis, and acetaminophen overdose. Finally, biomarkers, proteomic, and antioxidant therapies will be discussed as areas for future therapeutic interventions.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20400112      PMCID: PMC2907433          DOI: 10.1016/j.jss.2009.10.006

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  182 in total

1.  Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage.

Authors:  T R Billiar; R D Curran; B G Harbrecht; D J Stuehr; A J Demetris; R L Simmons
Journal:  J Leukoc Biol       Date:  1990-12       Impact factor: 4.962

2.  Comparison of superoxide dismutase, allopurinol, coenzyme Q10, and glutathione for the prevention of warm ischemic injury.

Authors:  W H Cho; D G Kim; N Murase; H J Mischinger; S Todo; T E Starzl
Journal:  Transplantation       Date:  1990-08       Impact factor: 4.939

3.  Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.

Authors:  P M Harrison; R Keays; G P Bray; G J Alexander; R Williams
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

4.  Nitric oxide: an endogenous modulator of leukocyte adhesion.

Authors:  P Kubes; M Suzuki; D N Granger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat.

Authors:  R J Nauta; E Tsimoyiannis; M Uribe; D B Walsh; D Miller; A Butterfield
Journal:  Surg Gynecol Obstet       Date:  1990-08

6.  Sodium flux and bioenergetics in the ischemic rat liver.

Authors:  H Blum; M D Osbakken; R G Johnson
Journal:  Magn Reson Med       Date:  1991-04       Impact factor: 4.668

Review 7.  Reactive oxygen and ischemia/reperfusion injury of the liver.

Authors:  H Jaeschke
Journal:  Chem Biol Interact       Date:  1991       Impact factor: 5.192

8.  IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism.

Authors:  S Mellouk; S J Green; C A Nacy; S L Hoffman
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

9.  Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure.

Authors:  P M Harrison; J A Wendon; A E Gimson; G J Alexander; R Williams
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

10.  L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation.

Authors:  A Nüssler; J C Drapier; L Rénia; S Pied; F Miltgen; M Gentilini; D Mazier
Journal:  Eur J Immunol       Date:  1991-01       Impact factor: 5.532

View more
  29 in total

Review 1.  Role of nitric oxide in hepatic ischemia-reperfusion injury.

Authors:  Arunotai Siriussawakul; Ahmed Zaky; John D Lang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Dihydro-stilbene gigantol relieves CCl4-induced hepatic oxidative stress and inflammation in mice via inhibiting C5b-9 formation in the liver.

Authors:  Ya-Ru Xue; Sheng Yao; Qian Liu; Zhao-Liang Peng; Qiang-Qiang Deng; Bo Liu; Zheng-Hua Ma; Le Wang; Hu Zhou; Yang Ye; Guo-Yu Pan
Journal:  Acta Pharmacol Sin       Date:  2020-05-13       Impact factor: 6.150

3.  Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.

Authors:  M Hanief Sofi; Yongxia Wu; Steven D Schutt; Min Dai; Anusara Daenthanasanmak; Jessica Heinrichs Voss; Hung Nguyen; David Bastian; Supinya Iamsawat; Shanmugam Panneer Selvam; Chen Liu; Nilanjana Maulik; Besim Ogretmen; Junfei Jin; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2019-05-02       Impact factor: 14.808

Review 4.  Nitric oxide in liver diseases.

Authors:  Yasuko Iwakiri; Moon Young Kim
Journal:  Trends Pharmacol Sci       Date:  2015-05-28       Impact factor: 14.819

Review 5.  Food components with antifibrotic activity and implications in prevention of liver disease.

Authors:  Minkyung Bae; Young-Ki Park; Ji-Young Lee
Journal:  J Nutr Biochem       Date:  2017-11-16       Impact factor: 6.048

6.  The role of iNOS in cholesterol-induced liver fibrosis.

Authors:  Sarit Anavi; Michal Eisenberg-Bord; Michal Hahn-Obercyger; Olga Genin; Mark Pines; Oren Tirosh
Journal:  Lab Invest       Date:  2015-06-22       Impact factor: 5.662

Review 7.  Oxidative stress as a crucial factor in liver diseases.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

8.  Regulation of alternative macrophage activation in the liver following acetaminophen intoxication by stem cell-derived tyrosine kinase.

Authors:  Carol R Gardner; Pamela Hankey; Vladimir Mishin; Mary Francis; Shan Yu; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2012-05-01       Impact factor: 4.219

9.  Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay.

Authors:  Elena Grossini; Kevin Bellofatto; Serena Farruggio; Lorenzo Sigaudo; Patrizia Marotta; Giulia Raina; Veronica De Giuli; David Mary; Piero Pollesello; Rosalba Minisini; Mario Pirisi; Giovanni Vacca
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

10.  Reactive oxygen and nitrogen species in sepsis-induced hepatic microvascular dysfunction.

Authors:  Georg Singer; Karen Y Stokes; D Neil Granger
Journal:  Inflamm Res       Date:  2012-10-18       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.